Public Relations

Credit Suisse swings into profit in Q3

Swiss banking major Credit Suisse Group today returned into black with a third quarter profit of 2,354 million Swiss francs, riding on the strong performance by its investment banking business. - Rain Commodities" Q2 net down 30% at Rs 120 cr - Allahabad Bank"s Q2 net jumps eight times - Biocon Q2 PAT up 192 % at Rs 74 cr - Pidilite Industries" Q2 net up 158% at Rs 85 cr - SBT profit rises 7.6% to Rs 122 cr - TCS Q2 net up 29% at Rs 1,642 cr Credit Suisse had registered a loss of 1.26 billion Swiss francs in the third quarter of 2008, it said in a statement. The bank"s net revenues rose to 8.91 billion Swiss francs in the three months period ended September, against 3.02 billion Swiss francs in the same period last year. "Credit Suisse has responded to changes in the industry over the past two years with the accelerated implementation of our client-focused, capital-efficient strategy and reduced -risk business model". "Our third-quarter performance, including our strong return on equity of 25.1 per cent, shows that our approach continues to work well and is providing the foundation for sustainable, high-quality, lower volatility earnings," Credit Suisse Chief Executive Officer Brady W Dougan said. The investment banking segment"s income before taxes of 1,746 million Swiss francs in the Q3 was up by 5 per cent from what it was in the second quarter, as the business continued to execute its client-focused, capital-efficient strategy and maintain market share momentum across products and regions.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
UPDATE: FDA seizes Caraco drugs over norms violation
In a major setback to Sun Pharmaceutical Industries - the largest Indian drug maker in terms of market capitalisation, the US Food and Drug Administration (FDA) has seized all medicines produced by Sun’s US arm Caraco Pharmaceutical Laboratories, for repeated violations of manufacturing standards.
Popular Articles

Basu gets solemn farewell in final journey
Jyoti Basu remained as popular in death, as he was when alive. The Marxist patriarch’s far-reaching appeal ensured that the country’s political establishment, irrespective of party affiliations, paid its last respects to him on Tuesday, save Trinamool Congress chief Mamata Banerjee.

Caraco shock: Sun Pharma to revise guidance
Sun Pharma today said it would revise the revenue guidance for 2009-10 as the company was not sure when its US subsidiary, Caraco Pharmaceuticals, would be able to meet the regulatory standards of the Food and Drug Administration (USFDA).